Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
Inari Medical Inc is a medical devices business based in the US. Inari Medical shares (NARI) are listed on the NASDAQ and all prices are listed in US Dollars. Inari Medical employs 456 staff and has a trailing 12-month revenue of around 0.00.
Our top pick for
Long-term investors
Our top pick for
Beginners
Our top pick for
Active traders
| Latest market close | $67.50 |
|---|---|
| 52-week range | $65.83 - $127.42 |
| 50-day moving average | $84.34 |
| 200-day moving average | $87.68 |
| Wall St. target price | $121.00 |
| PE ratio | 241.7958 |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | $0.28 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $67.5 from 2022-01-26
| 1 week (2022-01-20) | -8.15% |
|---|---|
| 1 month (2021-12-28) | -26.62% |
| 3 months (2021-10-28) | -24.58% |
| 6 months (2021-07-28) | -24.74% |
| 1 year (2021-01-28) | -29.14% |
|---|---|
| 2 years (2020-01-24) | N/A |
| 3 years (2019-01-24) | N/A |
| 5 years (2017-01-24) | N/A |
Valuing Inari Medical stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Inari Medical's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Inari Medical's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 242x. In other words, Inari Medical shares trade at around 242x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Inari Medical's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $28.3 million.
The EBITDA is a measure of a Inari Medical's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $242.4 million |
|---|---|
| Operating margin TTM | 10.62% |
| Gross profit TTM | $127.8 million |
| Return on assets TTM | 6.46% |
| Return on equity TTM | 7.38% |
| Profit margin | 6.49% |
| Book value | $4.67 |
| Market capitalisation | $3.4 billion |
TTM: trailing 12 months
We're not expecting Inari Medical to pay a dividend over the next 12 months.
Inari Medical, Inc. , a commercial-stage medical device company, focuses on developing products to treat and transform the lives of patients suffering from venous diseases in the United States. It offers ClotTriever for treatment of deep vein thrombosis; and FlowTriever, a thrombectomy system for treatment of pulmonary embolism. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc.
Lido’s liquid staking allows investors holding LUNA and less than 32 ETH to reap the rewards of DeFi staking.
Downturns often let you buy fundamentally strong stocks at bargain prices, but mind the fundamentals and consider these 3 rules.
The crypto market wiped out $1.5 trillion in value in just three months.
Bitcoin breached the $40,000 price level and may plummet lower as Russia signals a potential ban.
Cardano’s first metaverse project is available to investors now — if you can find a piece of digital land on sale. Plots sold fast despite the project’s early stage limitations.
Walmart files trademarks with the goal to issue its own cryptocurrency and NFTs for use in its digital stores.
Melania Trump launched an NFT platform — you can buy an image of her eyes.
Read our expert analysis on Vigorus and how the token will perform in the future.
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
Starting Jan. 18, every household can order up to four free at-home COVID-19 tests. But you’ll have to wait for them.